Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |